agilon health Amends Credit Agreement, Extends Maturities to 2028 Amidst Financial Restructuring
AGL is trading near its 52-week low of $0.338 (10% above the low).
Summary
agilon health, inc. has amended its credit agreement, extending the maturity dates of its term loans and revolving credit facility to February 2028, a critical move following its recent proposal for a reverse stock split.
Key Events · Financing and Capital Events · AGL
-
Maturity Extension
The stated maturity dates for the credit agreement, including initial term loans and revolving credit commitments, have been extended from February 18, 2026, to February 18, 2028.
-
Revolving Credit Reduction
The aggregate revolving credit commitments were reduced from $100.0 million to $90.0 million.
-
New Financial Covenants
The company is now required to maintain a minimum of $50 million in Total Cash and certain payments, including dividends, are conditioned on achieving positive EBITDA for two consecutive trailing four-quarter periods.
-
Parent Guaranty
agilon health, inc. (Parent) executed an unsecured guaranty for the obligations under the amended credit agreement.
Analysis · AGL · Industrial Applications And Services
This 8-K filing details a significant amendment to agilon health's credit agreement, extending the maturity dates for both its term loans and revolving credit facility from February 2026 to February 2028. This extension is a crucial development, especially in light of the company's recent proposal for a reverse stock split to address its low share price. While providing much-needed financial runway, the amendment introduces more restrictive terms, including a reduction in the revolving credit commitments from $100 million to $90 million and a new requirement to maintain a minimum of $50 million in total cash. Additionally, certain payments, including dividends, are now conditioned on achieving positive EBITDA for two consecutive trailing four-quarter periods, reflecting increased caution from lenders. The parent company also provided an unsecured guaranty for the obligations. The deferral of significant principal payments on the term loans to later dates provides immediate cash flow relief, but the overall stricter financial covenants underscore the company's ongoing efforts to stabilize its financial position.
At the time of this filing, AGL was trading at $0.37 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $150.7M. The 52-week trading range was $0.34 to $6.08. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.